Dorman Products, Inc. DORM 深 滬
等待開盤 04-07 09:30:00 美东时间
100.50
-0.400
-0.40%
華盛通- 最 高100.8333
- 今 開99.85
- 成交量 18.47万股
- 最 低 99.19
- 昨 收 100.90
- 總市值 30.33亿
- 52周最高 166.89
- 市盈率 靜 15.14
- 換手率 0.61%
- 52周最低 98.445
- 委 比 -31.03%
- 總股本 3018.33万
- 歷史最高 166.89
- 量 比 0.80
- 振 幅 1.63%
- 歷史最低 13.285
- 每 手 1
- 風險率 15.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Dorman Products Appoints CEO Kevin Olsen As Board Chairman, Succeeding Steven Berman
Dorman Products, Inc. (the "Company" or "Dorman") (NASDAQ: DORM), a leading supplier in the motor vehicle aftermarket industry, today announced that its Board of Directors has appointed Kevin Olsen, the Company's
04-02 20:02
Dorman Products, Inc. Names Kevin Olsen Chairman of The Board
<p>Dorman Products announced that Kevin Olsen has been appointed as Chairman of the Board, succeeding Steven Berman, who will remain on the Board. The move reflects confidence in Olsen's leadership and coincides with the company's strong performance. Olsen has been CEO since 2019 and previously served as CFO and COO. Berman, who started his board service in 1978, is praised for his long-term contributions to the company's growth. The company high...
04-02 12:00
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
Stephens & Co. Reiterates Overweight on Dorman Products, Maintains $150 Price Target
Stephens & Co. analyst Jeff Lick reiterates Dorman Products (NASDAQ:DORM) with a Overweight and maintains $150 price target.
03-18 20:35
美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
U.S. RESEARCH ROUNDUP-Aardvark Therapeutics, Chevron, Crowdstrike
U.S. RESEARCH ROUNDUP-Aardvark Therapeutics, Chevron, Crowdstrike March 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aardvark Therapeutics, Chevron and Crowdstrike, on Monday. HIGHLIGHTS * Aardvark Therapeutics Inc
03-02 15:29
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
财报速睇 | Dorman Products, Inc. 2025财年年度营收21.30亿美元，同比增长6.0%；归母净利润2.04亿美元，同比增长7.5%
华盛资讯2月28日讯，Dorman Products, Inc.公布2025财年年度业绩，公司年度营收21.30亿美元，同比增长6.0%，归母净利润2.04亿美元，同比增长7.5%。
02-28 06:50
Wells Fargo Maintains Overweight on Dorman Products, Lowers Price Target to $140
Wells Fargo analyst David Lantz maintains Dorman Products (NASDAQ:DORM) with a Overweight and lowers the price target from $150 to $140.
02-27 23:42
财报速睇 | Dorman Products, Inc. 2025财年Q4营收5.38亿美元，同比增长0.8%；归母净利润0.12亿美元，同比下滑78.8%
华盛资讯2月26日讯，Dorman Products, Inc.公布2025财年Q4业绩，公司Q4营收5.38亿美元，同比增长0.8%，归母净利润0.12亿美元，同比下滑78.8%。
02-26 07:54
